S. Giuliano

发表

Senescent cells develop a PARP-1 and nuclear factor-{kappa}B-associated secretome (PNAS).

K. Bille, C. Bertolotto, R. Ballotti, 2011, Genes & Development.

Microphthalmia-associated transcription factor controls the DNA damage response and a lineage-specific senescence program in melanomas.

Laurent Beuret, K. Bille, P. Bahadoran, 2010, Cancer research.

Involvement of FKHRL1 in melanoma cell survival and death

K. Bille, J. Ortonne, C. Bertolotto, 2008, Pigment cell & melanoma research.

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

Mark R. Marten, Erinna F. Lee, Dana L. Miller, 2021, Autophagy.

Guidelines for the use and interpretation of assays formonitoring autophagy (3rd edition)

Sangeeta Khare, Xin Qi, Ying Wang, 2016 .

Aurora B Is Regulated by the Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase (MAPK/ERK) Signaling Pathway and Is a Valuable Potential Target in Melanoma Cells*

K. Bille, P. Bahadoran, C. Bertolotto, 2012, The Journal of Biological Chemistry.

Autophagy plays a critical role in the degradation of active RHOA, the control of cell cytokinesis, and genomic stability.

D. Klionsky, Amine Belaid, P. Brest, 2013, Cancer research.

Genetic Disruption of the Multifunctional CD98/LAT1 Complex Demonstrates the Key Role of Essential Amino Acid Transport in the Control of mTORC1 and Tumor Growth.

J. Pouysségur, M. Palacín, Sandy Giuliano, 2016, Cancer research.

New CXCR1/CXCR2 inhibitors represent an effective treatment for kidney or head and neck cancers sensitive or refractory to reference treatments

M. Montès, G. Pagès, P. Auberger, 2019, Theranostics.

Secretome from senescent melanoma engages the STAT3 pathway to favor reprogramming of naive melanoma towards a tumor-initiating cell phenotype

V. Bonazzi, K. Bille, P. Bahadoran, 2013, Oncotarget.

A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma

S. Puig, L. Thomas, S. Richard, 2011, Nature.

CXCL7 is a predictive marker of sunitinib efficacy in clear cell renal cell carcinomas

C. Porta, N. Rioux-Leclercq, R. Schiappa, 2017, British Journal of Cancer.

Advances in melanoma senescence and potential clinical application

C. Bertolotto, R. Ballotti, Sandy Giuliano, 2011, Pigment cell & melanoma research.

The CXCL7/CXCR1/2 axis is a key driver in the growth of clear cell renal cell carcinoma.

J. Scoazec, G. Pagès, R. Grépin, 2014, Cancer research.

Therapeutics , Targets , and Chemical Biology The CXCL 7 / CXCR 1 / 2 Axis Is a Key Driver in the Growth of Clear Cell Renal Cell Carcinoma

J. Scoazec, E. Chamorey, D. Ambrosetti, 2014 .

Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells.

C. Bertolotto, I. Ben-Sahra, Y. Le Marchand-Brustel, 2010, Cancer research.

Mechanisms of resistance to anti-angiogenesis therapies.

G. Pagès, Sandy Giuliano, S. Giuliano, 2013, Biochimie.

Sunitinib Stimulates Expression of VEGFC by Tumor Cells and Promotes Lymphangiogenesis in Clear Cell Renal Cell Carcinomas.

Lindsay S. Cooley, A. Ravaud, J. Bernhard, 2017, Cancer research.

Resistance to sunitinib in renal clear cell carcinoma results from sequestration in lysosomes and inhibition of the autophagic flux

N. Mazure, G. Pagès, P. Auberger, 2015, Autophagy.

IGF1 promotes resistance to apoptosis in melanoma cells through an increased expression of BCL2, BCL-X(L), and survivin.

K. Bille, J. Ortonne, C. Bertolotto, 2008, The Journal of investigative dermatology.

Plk1, upregulated by HIF-2, mediates metastasis and drug resistance of clear cell renal cell carcinoma

Lindsay S. Cooley, K. Bensalah, N. Rioux-Leclercq, 2021, Communications Biology.

A novel mechanism of HIF2-dependent PLK1-mediated metastasis and drug resistance of clear cell Renal Cell Carcinoma

Lindsay S. Cooley, K. Bensalah, N. Rioux-Leclercq, 2020 .

Inhibition of the amino‐acid transporter LAT1 demonstrates anti‐neoplastic activity in medulloblastoma

J. Pouysségur, G. Pagès, H. Endou, 2019, Journal of cellular and molecular medicine.

The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5)

J. Pouysségur, Sandy Giuliano, H. Endou, 2018, The Journal of Biological Chemistry.

Knockout of Vdac1 activates hypoxia-inducible factor through reactive oxygen species generation and induces tumor growth by promoting metabolic reprogramming and inflammation

M. Ivan, W. Craigen, J. Pouysségur, 2015, Cancer & metabolism.

FANCD2 functions as a critical factor downstream of MiTF to maintain the proliferation and survival of melanoma cells

C. Bertolotto, R. Ballotti, F. Rosselli, 2016, Scientific Reports.

Pharmacological inhibition of the amino-acid transporter LAT1 demonstrates in vitro anti-neoplastic activity towards medulloblastoma

J. Pouysségur, G. Pagès, H. Endou, 2018, bioRxiv.

Structural and functional analysis of coral Hypoxia Inducible Factor

D. Allemand, G. Pagès, S. Tambutté, 2017, PloS one.

VEGFC acts as a double-edged sword in renal cell carcinoma aggressiveness

N. Rioux-Leclercq, G. Pagès, P. Lenormand, 2019, Theranostics.

Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

Sara W. Bird, Erinna F. Lee, Michael D. Kim, 2016 .

Editorial :Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). DOI: 10.1080/15548627.2015.1100356;WOS:000373595400001; 2-s2.0-85013763791&;PMID: 26799652

Lee, Duchen, Izzo, 2016 .

Resistance to lysosomotropic drugs used to treat kidney and breast cancers involves autophagy and inflammation and converges in inducing CXCL5

N. Rioux-Leclercq, G. Pagès, V. Imbert, 2019, Theranostics.

Soluble CD146 is a predictive marker of pejorative evolution and of sunitinib efficacy in clear cell renal cell carcinoma

K. Bensalah, N. Rioux-Leclercq, A. Ravaud, 2018, Theranostics.

Soluble CD 146 is a predictive marker of pejorative evolution and of sunitinib efficacy in clear cell renal cell carcinoma

K. Bensalah, N. Rioux-Leclercq, A. Ravaud, 2018 .

Apoptosis in Prostate Cancer Cells Metformin and 2-Deoxyglucose Induces p 53-Dependent Targeting Cancer Cell Metabolism : The Combination of

C. Bertolotto, I. Ben-Sahra, J. Tanti, 2010 .

Corrigendum: A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma

S. Puig, L. Thomas, S. Richard, 2015, Nature.

Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells

P. Bahadoran, C. Bertolotto, R. Ballotti, 2012, Oncogene.

Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma

C. Bertolotto, R. Ballotti, S. Gras, 2011, Oncogene.

The ELR+CXCL chemokines and their receptors CXCR1/CXCR2

G. Pagès, Sandy Giuliano, R. Grépin, 2014, Oncoimmunology.

Aurora B Is Regulated by the Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase (MAPK/ERK) Signaling Pathway and Is a Valuable Potential Target in Melanoma Cells*

K. Bille, P. Bahadoran, C. Bertolotto, 2012, The Journal of Biological Chemistry.

Involvement of FKHRL1 in melanoma cell survival and death

K. Bille, C. Bertolotto, R. Ballotti, 2008, Pigment cell & melanoma research.

Should evidence of an autolysosomal de-acidification defect in Alzheimer and Parkinson diseases call for caution in prescribing chronic PPI and DMARD?

D. Klionsky, P. Brest, B. Mograbi, 2023, Autophagy.